









Märkte
/
Aktien
/
nasdaq-enov
/

Enovis Corp

ENOV

32.540USD

+0.960+3.04%

Trading geöffnet （ET）Kurse um 15 Minuten verzögert

1.86BMarktkapitalisierung

VerlustKGV TTM



Enovis Corp

32.540

+0.960+3.04%

Übersicht Unternehmen Finanzen Analyse

Analyse

mehr Informationen über Enovis Corp Unternehmen

Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment develops, manufactures, and distributes rigid bracing products, orthopedic soft goods, vascular systems and compression garments, and hot and cold therapy products and offers recovery sciences products in the clinical rehabilitation and sports medicine markets, such as bone growth stimulators and electrical stimulators used for pain management. The Reconstructive segment develops, manufactures, and markets a variety of knee, hip, shoulder, elbow, foot, ankle, and finger implant products and surgical productivity tools. It also provides Novastep, a minimally invasive surgery (MIS) foot and ankle solutions.

Unternehmensinformationen

BörsenkürzelENOV

Name des UnternehmensEnovis Corp

IPO-datumMay 08, 2008

CEOMr. Damien Mcdonald

Anzahl der mitarbeiter7367

WertpapierartOrdinary Share

GeschäftsjahresendeMay 08

Addresse2711 Centerville Road

StadtWILMINGTON

BörseNYSE Consolidated

LandUnited States of America

Postleitzahl19808

Telefon13022529160

Websitehttps://www.enovis.com/

BörsenkürzelENOV

IPO-datumMay 08, 2008

CEOMr. Damien Mcdonald

Führungskräfte

Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Daniel Alexis Pryor

Executive Vice President - Strategy and Business Development

114.51K

+9.57%

Mr. Damien Mcdonald

Chief Executive Officer, Director

96.30K

Mr. Terry D. Ross

Group President - Prevention and Recovery

35.79K

-0.90%

Ms. Sharon L. Wienbar

Independent Chairman of the Board

28.26K

+30.46%

Mr. Rajiv Vinnakota

Independent Director

20.37K

+47.89%

Mr. Liam J. Kelly

Independent Director

15.27K

+76.12%

Ms. Barbara W. Bodem

Independent Director

10.52K

+168.36%

Dr. Christine Ortiz, Ph.D.

Independent Director

10.52K

+168.36%

Mr. Philip A. Okala

Independent Director

Ms. Angela S. Lalor

Independent Director

Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Daniel Alexis Pryor

Executive Vice President - Strategy and Business Development

114.51K

+9.57%

Mr. Damien Mcdonald

Chief Executive Officer, Director

96.30K

Mr. Terry D. Ross

Group President - Prevention and Recovery

35.79K

-0.90%

Ms. Sharon L. Wienbar

Independent Chairman of the Board

28.26K

+30.46%

Mr. Rajiv Vinnakota

Independent Director

20.37K

+47.89%

Mr. Liam J. Kelly

Independent Director

15.27K

+76.12%

Umsatzaufteilung

Währung: USDAktualisiert: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

International Reconstructive

148.37M

26.55%

U.S. Reconstructive

137.88M

24.67%

U.S. Bracing & Support

115.09M

20.59%

International P&R

90.88M

16.26%

U.S. Other P&R

66.62M

11.92%

Keine Daten

Nach Geschäftsbereich

Nach Region

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

International Reconstructive

148.37M

26.55%

U.S. Reconstructive

137.88M

24.67%

U.S. Bracing & Support

115.09M

20.59%

International P&R

90.88M

16.26%

U.S. Other P&R

66.62M

11.92%

Aktionärsstatistik

Aktualisiert: Tue, Aug 19

Aktionäre

Aktionärstypen

Aktionäre

Anteil

BlackRock Institutional Trust Company, N.A.

14.03%

The Vanguard Group, Inc.

11.14%

American Century Investment Management, Inc.

8.29%

Dimensional Fund Advisors, L.P.

5.11%

Davenport Asset Management

4.82%

Andere

56.62%

Aktionäre

Anteil

BlackRock Institutional Trust Company, N.A.

14.03%

The Vanguard Group, Inc.

11.14%

American Century Investment Management, Inc.

8.29%

Dimensional Fund Advisors, L.P.

5.11%

Davenport Asset Management

4.82%

Andere

56.62%

Aktionärstypen

Aktionäre

Anteil

Investment Advisor

61.34%

Investment Advisor/Hedge Fund

37.68%

Hedge Fund

14.15%

Research Firm

5.57%

Individual Investor

1.58%

Bank and Trust

1.27%

Pension Fund

1.11%

Venture Capital

0.13%

Sovereign Wealth Fund

0.05%

Institutionelle Beteiligung

Aktualisiert: Tue, Jul 1

Berichtszeitraum

Anzahl der Institutionen

Gehaltenen Aktien

Anteil

Veränderung

2025Q2

641

62.33M

109.11%

-9.18M

2025Q1

646

68.39M

119.73%

-3.70M

2024Q4

637

64.20M

113.02%

-5.55M

2024Q3

613

62.53M

111.92%

-6.94M

2024Q2

617

64.91M

118.38%

-5.04M

2024Q1

651

62.70M

114.40%

-9.13M

2023Q4

661

61.64M

112.95%

-6.99M

2023Q3

653

60.52M

110.96%

-10.76M

2023Q2

641

59.95M

109.96%

-8.07M

2023Q1

643

57.38M

105.33%

-9.99M

Aktionärsaktivitäten

Name

Gehaltenen Aktien

Anteil

Veränderung

Änderung%

Datum

BlackRock Institutional Trust Company, N.A.

6.52M

11.41%

+1.67M

+34.39%

Mar 31, 2025

The Vanguard Group, Inc.

6.08M

10.64%

-7.15K

-0.12%

Mar 31, 2025

American Century Investment Management, Inc.

3.52M

6.17%

+369.48K

+11.71%

Mar 31, 2025

Dimensional Fund Advisors, L.P.

2.93M

5.12%

+27.89K

+0.96%

Mar 31, 2025

Davenport Asset Management

3.07M

5.38%

-206.82K

-6.31%

Mar 31, 2025

State Street Global Advisors (US)

1.89M

3.32%

+162.41K

+9.37%

Mar 31, 2025

Royce Investment Partners

2.49M

4.36%

+20.23K

+0.82%

Mar 31, 2025

Hood River Capital Management LLC

1.44M

2.53%

+781.15K

+118.10%

Mar 31, 2025

River Road Asset Management, LLC

1.39M

2.44%

+153.53K

+12.40%

Mar 31, 2025

Verbundene ETFs

Aktualisiert: Wed, Aug 6

Name

Anteil

SPDR S&P Health Care Equipment ETF

1.72%

Invesco S&P SmallCap Health Care ETF

1.03%

Invesco S&P SmallCap 600 Pure Value ETF

0.5%

VictoryShares US Small Mid Cap Value Momentum ETF

0.31%

SPDR S&P 600 Small Cap Value ETF

0.28%

First Trust Small Cap Growth AlphaDEX Fund

0.27%

iShares S&P Small-Cap 600 Value ETF

0.24%

Avantis US Small Cap Equity ETF

0.21%

iShares U.S. Medical Devices ETF

0.2%

SPDR S&P SmallCap 600 ESG ETF

0.19%

SPDR S&P Health Care Equipment ETF

Anteil1.72%

Invesco S&P SmallCap Health Care ETF

Anteil1.03%

Invesco S&P SmallCap 600 Pure Value ETF

Anteil0.5%

VictoryShares US Small Mid Cap Value Momentum ETF

Anteil0.31%

SPDR S&P 600 Small Cap Value ETF

Anteil0.28%

First Trust Small Cap Growth AlphaDEX Fund

Anteil0.27%

iShares S&P Small-Cap 600 Value ETF

Anteil0.24%

Avantis US Small Cap Equity ETF

Anteil0.21%

iShares U.S. Medical Devices ETF

Anteil0.2%

SPDR S&P SmallCap 600 ESG ETF

Anteil0.19%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.

Datum

Dividende

Stichtag für die Aktienregistrierung

Zahltag

Ex-Dividendentag

Keine Daten

Aktien-Split

Datum

Art

Verhältnis

Mar 18, 2022

Merger

3→1

Mar 18, 2022

Merger

3→1

Mar 18, 2022

Merger

3→1

Mar 18, 2022

Merger

3→1

Datum

Art

Verhältnis

Mar 18, 2022

Merger

3→1

Mar 18, 2022

Merger

3→1

Mar 18, 2022

Merger

3→1

Mar 18, 2022

Merger

3→1

KeyAI

